Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04495751 · ClinicalTrials.gov registry record · Early Phase 1
Muscadine Grape Extract to Improve Fatigue
A Early Phase 1 study of Fatigue, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT04495751 is a Early Phase 1 study of Fatigue that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 64 participants, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04495751, a Early Phase 1 study of Fatigue, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to see if muscadine grape extract improves fatigue in people age 70 and above who have a history of treated cancer and report the symptom of fatigue.
Conditions Studied
Interventions
- DRUG Placebo
- OTHER Questionnaires
- OTHER Quality of Life Assessment
- DIETARY_SUPPLEMENT Muscadine grape extract
- OTHER Participant Feedback
Study Locations (1)
North Carolina
- Wake Forest Baptist Comprehensive Cancer Center - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2021-04-20 |
| Est. Completion | 2024-08-26 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04495751
The ClinicalTrials.gov registry entry for NCT04495751 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (71% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fatigue appearing as the primary indexed condition, and to 5 interventions - of which Placebo is the first listed.
NCT04495751 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT04495751 about?
NCT04495751 is a clinical study titled "Muscadine Grape Extract to Improve Fatigue". The purpose of this research is to see if muscadine grape extract improves fatigue in people age 70 and above who have a history of treated cancer and report the symptom of fatigue.
What is the current status of trial NCT04495751?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 64 participants. The study started on 2021-04-20. Estimated completion is 2024-08-26.
What conditions does trial NCT04495751 study?
This clinical trial studies the following conditions: Fatigue.
What interventions are being tested in trial NCT04495751?
The interventions under investigation include: Placebo (DRUG), Questionnaires (OTHER), Quality of Life Assessment (OTHER), Muscadine grape extract (DIETARY_SUPPLEMENT), Participant Feedback (OTHER).
Who is sponsoring clinical trial NCT04495751?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04495751 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fatigue
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Aspirin as a Pre-Treatment for Exercise in Multiple Sclerosis
COMPLETED · Early Phase 1
-
Fatigue and Cognitive Demand With Aging
RECRUITING · NA
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
-
Behavioral and Neural Correlates of Post-Stroke Fatigue
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
-
Eccentric Exercise and Fatigue in Multiple Sclerosis
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.